Safety, Performance of CEREGLIDE 92 Intermediate Catheter in Treatment of Acute Ischemic Stroke

Inclusion Criteria: * Diagnosis of acute ischemic stroke. * NIHSS ≥6 * Baseline mRS ≤ 2 * Completed informed consent. Exclusion Criteria: * Known pregnancy. * Life expectancy less than 90 days prior to stroke onset. * Known Diagnosis of Dementia * Treatment with heparin within 48 hours. * Clinical history, past imaging or clinical judgement suggest that the intracranial occlusion is chronic. * Computed tomography (CT) or Magnetic Resonance Imaging (MRI) evidence of recent/ fresh hemorrhage on presentation. * Baseline CT or MRI showing mass effect * Concurrent sino-venous thrombosis * Currently participating in an investigational (drug, device, etc.) clinical trial, excluding trials in observational, natural history, and/or epidemiological studies not involving intervention and that will not confound study endpoints. Sponsor approval is required.